Eosinophilia during letermovir treatment after allogeneic hematopoietic stem cell transplantation

被引：0
|
作者：
Hiroki Hosoi
Shogo Murata
Toshiki Mushino
Akinori Nishikawa
Takashi Sonoki
机构：
[1] Wakayama Medical University,Department of Hematology/Oncology
来源：
Annals of Hematology | 2020年 / 99卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2453 / 2454
页数：1
相关论文
共 50 条
  • [1] Eosinophilia during letermovir treatment after allogeneic hematopoietic stem cell transplantation
    Hosoi, Hiroki
    Murata, Shogo
    Mushino, Toshiki
    Nishikawa, Akinori
    Sonoki, Takashi
    [J]. ANNALS OF HEMATOLOGY, 2020, 99 (10) : 2453 - 2454
  • [2] Letermovir for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplantation
    Azharuddin, Md
    Sharma, Manju
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 149 - 149
  • [3] Pharmacokinetics of Tacrolimus Coadministered With Letermovir in Allogeneic Hematopoietic Stem Cell Transplantation Patients
    Guo, Yong-mei
    Abumiya, Maiko
    Yamashita, Takaya
    Ubukawa, Kumi
    Takahashi, Naoto
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (03): : 411 - 412
  • [4] BONE MARROW EOSINOPHILIA CORRELATES WITH TREATMENT OUTCOMES BOTH AFTER AUTOLOGOUS AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Georgieva, Y.
    Petrov, Y.
    Spassov, B.
    Balatzenko, G.
    Ganeva, P.
    Madzharova, V.
    Mihaylov, G.
    Arnaudov, G.
    Guenova, M.
    [J]. HAEMATOLOGICA, 2015, 100 : 615 - 616
  • [5] Letermovir in Allogeneic Hematopoietic Cell Transplantation: Beyond the Label
    Lin, Andrew
    Maloy, Molly A.
    Bhatt, Valkal
    DeRespiris, Lauren
    Griffin, Meagan
    Lau, Carmen
    Proli, Anthony J.
    Barker, Juliet N.
    Shaffer, Brian C.
    Giralt, Sergio A.
    Jakubowski, Ann A.
    Papadopoulos, Esperanza B.
    Papanicolaou, Genovefa A.
    Seo, Susan K.
    Perales, Miguel-Angel
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [6] Drug interaction between letermovir and voriconazole after allogeneic hematopoietic cell transplantation
    Nakashima, Toshihisa
    Inamoto, Yoshihiro
    Fukushi, Yayoi
    Doke, Yoshiyuki
    Hashimoto, Hironobu
    Fukuda, Takahiro
    Yamaguchi, Masakazu
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (06) : 872 - 876
  • [7] Drug interaction between letermovir and voriconazole after allogeneic hematopoietic cell transplantation
    Toshihisa Nakashima
    Yoshihiro Inamoto
    Yayoi Fukushi
    Yoshiyuki Doke
    Hironobu Hashimoto
    Takahiro Fukuda
    Masakazu Yamaguchi
    [J]. International Journal of Hematology, 2021, 113 : 872 - 876
  • [8] Eosinophilia, Regardless of Degree, is Related to Better Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation
    Nakane, Takahiko
    Nakamae, Hirohisa
    Hirose, Asao
    Nakamae, Mika
    Koh, Hideo
    Hayashi, Yoshiki
    Nishimoto, Mitsutaka
    Umemoto, Yukari
    Yoshimura, Takuro
    Bingo, Masato
    Okamura, Hiroshi
    Yoshida, Masahiro
    Ichihara, Hiroyoshi
    Aimoto, Mizuki
    Terada, Yoshiki
    Nakao, Yoshitaka
    Ohsawa, Masahiko
    Hino, Masayuki
    [J]. INTERNAL MEDICINE, 2012, 51 (08) : 851 - 858
  • [9] Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation
    Maffini, Enrico
    Giaccone, Luisa
    Festuccia, Moreno
    Brunello, Lucia
    Busca, Alessandro
    Bruno, Benedetto
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (06) : 585 - 596
  • [10] Risk factor analysis for cytomegalovirus reactivation under prophylaxis with letermovir after allogeneic hematopoietic stem cell transplantation
    Mizuno, Kota
    Sakurai, Masatoshi
    Kato, Jun
    Yamaguchi, Kentaro
    Abe, Ryohei
    Koda, Yuya
    Kataoka, Keisuke
    Mori, Takehiko
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (06)
12345